Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

PURPOSE: Studies comparing CSF and PET tau biomarkers have included only commercial CSF assays examining specific phosphorylation sites (e.g. threonine 181, P-tau(181p)) and mid-domain tau (i.e. total tau, T-tau). Moreover, these studies did not examine CSF tau levels in relation to cerebral glucose...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Nucl Med Mol Imaging
Autores principales: Leuzy, Antoine, Cicognola, Claudia, Chiotis, Konstantinos, Saint-Aubert, Laure, Lemoine, Laetitia, Andreasen, Niels, Zetterberg, Henrik, Ye, Keqiang, Blennow, Kaj, Höglund, Kina, Nordberg, Agneta
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451715/
https://ncbi.nlm.nih.gov/pubmed/30610252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4242-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares